USANA Health Sciences (NYSE:USNA) Stock Price Down 6% – Time to Sell?

USANA Health Sciences, Inc. (NYSE:USNA)’s stock price traded down 6% on Friday . The company traded as low as $33.00 and last traded at $32.77. 68,031 shares were traded during trading, a decline of 41% from the average session volume of 116,075 shares. The stock had previously closed at $34.86.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. DA Davidson raised their target price on shares of USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a research report on Thursday, January 2nd. StockNews.com upgraded USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Saturday, December 28th.

USANA Health Sciences Trading Down 6.2 %

The business has a 50 day moving average of $36.05 and a two-hundred day moving average of $38.21. The firm has a market cap of $623.36 million, a P/E ratio of 11.55, a PEG ratio of 0.94 and a beta of 0.89.

Insider Buying and Selling at USANA Health Sciences

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of the firm’s stock in a transaction on Monday, November 4th. The stock was sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.33% of the company’s stock.

Institutional Trading of USANA Health Sciences

Large investors have recently bought and sold shares of the business. Pacer Advisors Inc. increased its position in USANA Health Sciences by 16.5% during the 3rd quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock worth $20,638,000 after purchasing an additional 76,904 shares in the last quarter. Pzena Investment Management LLC lifted its holdings in USANA Health Sciences by 7.5% during the 3rd quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock worth $39,801,000 after buying an additional 72,977 shares during the period. Allspring Global Investments Holdings LLC lifted its stake in shares of USANA Health Sciences by 14,068.2% in the third quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock worth $1,472,000 after acquiring an additional 38,547 shares during the period. Unison Advisors LLC bought a new stake in USANA Health Sciences in the third quarter valued at approximately $683,000. Finally, Assenagon Asset Management S.A. raised its holdings in USANA Health Sciences by 13.5% during the 3rd quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock worth $4,702,000 after purchasing an additional 14,756 shares during the last quarter. 54.25% of the stock is owned by institutional investors and hedge funds.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.